Guest Columns
-
Improving Drug-Device Combination Product Co-Development
8/8/2025
Early recognition and mitigation of drug and device integration difficulties are critical to the success of combination products. The collaborative effort in development cannot be overstated.
-
Latin America Is Becoming The Testing Ground For AI-Enabled Medical Device Clinical Trials
8/7/2025
This article explains why Latin America's demographic diversity, cost profile, and accelerating digital health infrastructure make it an ideal region for AI-enabled medical device clinical trials.
-
EMA Issues Revised Annex 11, New Annex 22, And Associated Documents On Data Governance
8/6/2025
The EMA issued three new draft documents in July, all related to the advancement of the use of electronic technology in GMP: AI, computerized systems, and documentation. The public comment period ends Oct. 7.
-
Minimizing The Impact Of Human Errors Using Relational Risk Analysis
8/4/2025
This article describes how a mechanism-based risk analysis approach can provide two complementary opportunities for minimizing the likelihood of a human error impacting pharmaceutical and medical device risks.
-
Medical Device Innovation In Brazil: Success Stories And Future Opportunities
7/28/2025
Brazil is rapidly establishing itself as a powerhouse in medical device innovation. This article shares market opportunities, success stories, and strategic recommendations for medical device manufacturers.
-
Critical Considerations For IP & Patents For Emerging Medical Device Companies
7/11/2025
As the medical device industry continues to expand, intellectual property (IP) considerations — especially those concerning patents — are critical for medical device innovators and manufacturers.
-
Brazil's Competitive Edge: Infrastructure And Operational Advantages For Medical Device Trials
7/10/2025
Explore the practical advantages that position Brazil at the forefront of medical device clinical trials in the region.
-
Audit Trail Compliance And What To Look For In Mitigation Software
7/9/2025
In the pharma/biotech and medical device industries, the audit trail is important to have for accountability, data integrity, repeatability to create an event for investigation, and regulatory compliance.
-
Cybersecurity Risk Management In Medical Devices: Practical Implementation Of FDA's 2025 Final Guidance
7/7/2025
The FDA has issued its much-anticipated final guidance on cybersecurity risk management in medical devices, effective June 2025.
-
Designing Wearables That Are Truly Patient-Centric
7/7/2025
There’s a distinct need to create wearables that interweave seamlessly into an individual’s lifestyle, encouraging adherence and gathering long-term, accurate diagnostic data.